交易 Galectin Therapeutics Inc. - GALT CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.0270 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026151% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003929% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Galectin Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Sep 28, 2023 | 1.8965 | 0.1300 | 7.36% | 1.7665 | 1.8965 | 1.7665 |
Sep 27, 2023 | 1.8065 | -0.0100 | -0.55% | 1.8165 | 1.8265 | 1.7665 |
Sep 26, 2023 | 1.7965 | -0.0300 | -1.64% | 1.8265 | 1.8565 | 1.7765 |
Sep 25, 2023 | 1.8365 | -0.0200 | -1.08% | 1.8565 | 1.8665 | 1.7665 |
Sep 22, 2023 | 1.7465 | 0.0300 | 1.75% | 1.7165 | 1.7765 | 1.6665 |
Sep 21, 2023 | 1.7665 | 0.0300 | 1.73% | 1.7365 | 1.7765 | 1.6965 |
Sep 20, 2023 | 1.7765 | -0.0800 | -4.31% | 1.8565 | 1.9165 | 1.7465 |
Sep 19, 2023 | 1.9165 | 0.0700 | 3.79% | 1.8465 | 1.9365 | 1.8465 |
Sep 18, 2023 | 1.9365 | 0.1600 | 9.01% | 1.7765 | 1.9565 | 1.7765 |
Sep 15, 2023 | 1.7565 | -0.1400 | -7.38% | 1.8965 | 1.9065 | 1.7365 |
Sep 14, 2023 | 1.9065 | -0.0600 | -3.05% | 1.9665 | 1.9665 | 1.8765 |
Sep 13, 2023 | 1.9065 | 0.0800 | 4.38% | 1.8265 | 1.9365 | 1.7865 |
Sep 12, 2023 | 1.7865 | 0.1400 | 8.50% | 1.6465 | 1.8065 | 1.6465 |
Sep 11, 2023 | 1.6665 | 0.0400 | 2.46% | 1.6265 | 1.6765 | 1.6265 |
Sep 8, 2023 | 1.7160 | 0.0100 | 0.59% | 1.7060 | 1.7360 | 1.7060 |
Sep 7, 2023 | 1.7360 | 0.1000 | 6.11% | 1.6360 | 1.7460 | 1.6360 |
Sep 6, 2023 | 1.6360 | -0.0400 | -2.39% | 1.6760 | 1.6760 | 1.6260 |
Sep 5, 2023 | 1.6960 | -0.0500 | -2.86% | 1.7460 | 1.7560 | 1.6360 |
Sep 1, 2023 | 1.7560 | 0.0800 | 4.77% | 1.6760 | 1.7560 | 1.6560 |
Aug 31, 2023 | 1.7460 | 0.0300 | 1.75% | 1.7160 | 1.7460 | 1.6660 |
Galectin Therapeutics Inc. Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Monday, November 13, 2023 | ||
时间(协调世界时) (UTC) 13:30 | 國家 US
| 事件 Q3 2023 Galectin Therapeutics Inc Earnings Release Q3 2023 Galectin Therapeutics Inc Earnings ReleaseForecast(預報) -上一頁 - |
Friday, December 1, 2023 | ||
时间(协调世界时) (UTC) 16:00 | 國家 US
| 事件 Galectin Therapeutics Inc Annual Shareholders Meeting Galectin Therapeutics Inc Annual Shareholders MeetingForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 38.352 | 30.179 | 23.444 | 13.438 | 13.602 |
銷售/一般/行政費用,總計 | 6.615 | 6.361 | 5.468 | 5.971 | 7.131 |
研究與開發 | 31.737 | 23.818 | 17.976 | 7.467 | 6.471 |
營業收入 | -38.352 | -30.179 | -23.444 | -13.438 | -13.602 |
利息收入(費用),非經營淨值 | -0.424 | -0.348 | -0.021 | 0.144 | -0.298 |
稅前淨收入 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 |
稅後淨收入 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 |
未計算非常項目前的淨收益 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 |
淨收入 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 |
Total Adjustments to Net Income | -0.097 | -0.171 | -0.137 | -6.885 | -1.147 |
普通股股東可獲收益 (不含非經常性項目) | -38.873 | -30.698 | -23.602 | -20.179 | -15.047 |
普通股股東可獲收益 (含非經常性項目) | -38.873 | -30.698 | -23.602 | -20.179 | -15.047 |
攤薄淨收入 | -38.873 | -30.698 | -23.602 | -20.179 | -15.047 |
攤薄後加權平均股 | 59.391 | 58.527 | 57.029 | 52.238 | 39.414 |
扣除特別項目的每股攤薄盈利 | -0.65453 | -0.52451 | -0.41386 | -0.38629 | -0.38177 |
每股正常攤薄盈利 | -0.65453 | -0.52451 | -0.41386 | -0.38629 | -0.38177 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 9.003 | 10.342 | 10.633 | 8.122 | 9.662 |
銷售/一般/行政費用,總計 | 1.632 | 1.543 | 1.626 | 1.524 | 1.588 |
研究與開發 | 7.371 | 8.799 | 9.007 | 6.598 | 8.074 |
營業收入 | -9.003 | -10.342 | -10.633 | -8.122 | -9.662 |
利息收入(費用),非經營淨值 | -0.111 | -1.185 | -0.001 | -0.475 | 0.049 |
稅前淨收入 | -9.114 | -11.527 | -10.634 | -8.597 | -9.613 |
稅後淨收入 | -9.114 | -11.527 | -10.634 | -8.597 | -9.613 |
未計算非常項目前的淨收益 | -9.114 | -11.527 | -10.634 | -8.597 | -9.613 |
淨收入 | -9.114 | -11.527 | -10.634 | -8.597 | -9.613 |
Total Adjustments to Net Income | -0.063 | 0 | -0.065 | 0.016 | -0.064 |
普通股股東可獲收益 (不含非經常性項目) | -9.177 | -11.527 | -10.699 | -8.581 | -9.677 |
普通股股東可獲收益 (含非經常性項目) | -9.177 | -11.527 | -10.699 | -8.581 | -9.677 |
攤薄淨收入 | -9.177 | -11.527 | -10.699 | -8.581 | -9.677 |
攤薄後加權平均股 | 59.582 | 59.48 | 59.424 | 59.396 | 59.389 |
扣除特別項目的每股攤薄盈利 | -0.15402 | -0.1938 | -0.18005 | -0.14447 | -0.16294 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.15402 | -0.1938 | -0.18005 | -0.14447 | -0.16294 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 20.552 | 41.82 | 29.465 | 48.209 | 8.832 |
現金和短期投資 | 18.592 | 39.648 | 27.142 | 47.48 | 8.253 |
現金等價物 | 18.592 | 39.648 | 27.142 | 47.48 | 8.253 |
預付的費用 | 1.96 | 2.172 | 2.323 | 0.729 | 0.579 |
總資産 | 21.285 | 41.827 | 29.6 | 48.467 | 9.006 |
物業/廠房/設備,總計 - 淨額 | 0.086 | 0.007 | 0.048 | 0.084 | 0 |
物業/廠房/設備,總計 - 總額 | 0.081 | 0.122 | 0.158 | 0.074 | |
累計折舊,總計 | -0.074 | -0.074 | -0.074 | -0.074 | |
無形資産,淨額 | 0 | ||||
流動負債總額 | 13.012 | 9.033 | 5.399 | 2.82 | 2.108 |
應付賬款 | 3.89 | 1.805 | 1.292 | 1.661 | 0.297 |
預提費用 | 9.058 | 7.163 | 4.042 | 1.093 | 1.512 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.064 | 0.065 | 0.065 | 0.066 | 0.299 |
負債總額 | 53.479 | 39.211 | 5.407 | 2.872 | 2.108 |
長期債務總額 | 39.828 | 29.048 | 0 | 0 | 0 |
總權益 | -32.194 | 2.616 | 24.193 | 45.595 | 6.898 |
Redeemable Preferred Stock | 2.233 | 2.25 | 2.25 | 2.26 | 2.26 |
Preferred Stock - Non Redeemable, Net | 6.682 | ||||
普通股 | 0.059 | 0.059 | 0.056 | 0.056 | 0.041 |
額外實收資本 | 275.081 | 271.001 | 261.883 | 259.673 | 194.13 |
留存收益(累計赤字) | -309.567 | -270.694 | -239.996 | -216.394 | -196.215 |
總負債和股東權益 | 21.285 | 41.827 | 29.6 | 48.467 | 9.006 |
已發行普通股總數 | 59.426 | 59.3413 | 57.0771 | 56.8946 | 41.1909 |
Total Preferred Shares Outstanding | 1.26018 | 1.30268 | 1.30268 | 1.32768 | 6.83568 |
其他長期資産,總計 | 0.647 | 0.087 | 0.174 | 0.174 | |
其他負債,總計 | 0.639 | 1.13 | 0.008 | 0.052 | |
長期債務 | 39.828 | 29.048 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 19.552 | 20.552 | 17.121 | 25.785 | 33.507 |
現金和短期投資 | 17.799 | 18.592 | 15.831 | 24.178 | 31.606 |
現金等價物 | 17.799 | 18.592 | 15.831 | 24.178 | 31.606 |
預付的費用 | 1.753 | 1.96 | 1.29 | 1.607 | 1.901 |
總資産 | 20.225 | 21.285 | 17.914 | 25.886 | 33.615 |
物業/廠房/設備,總計 - 淨額 | 0.078 | 0.086 | 0.093 | 0.101 | 0.108 |
其他長期資産,總計 | 0.595 | 0.647 | 0.7 | ||
流動負債總額 | 11.533 | 13.012 | 9.588 | 10.892 | 9.535 |
應付賬款 | 2.553 | 3.89 | 2.352 | 2.964 | 1.906 |
預提費用 | 8.98 | 9.058 | 7.236 | 7.864 | 7.629 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 0.064 | 0 | 0.064 | 0 |
負債總額 | 62.871 | 53.479 | 40.249 | 41.109 | 39.808 |
長期債務總額 | 49.941 | 39.828 | 29.734 | 29.504 | 29.275 |
其他負債,總計 | 1.397 | 0.639 | 0.927 | 0.713 | 0.998 |
總權益 | -42.646 | -32.194 | -22.335 | -15.223 | -6.193 |
Redeemable Preferred Stock | 2.233 | 2.233 | 2.233 | 2.233 | 2.25 |
普通股 | 0.059 | 0.059 | 0.059 | 0.059 | 0.059 |
額外實收資本 | 276.156 | 275.081 | 274.241 | 272.772 | 272.108 |
留存收益(累計赤字) | -321.094 | -309.567 | -298.868 | -290.287 | -280.61 |
總負債和股東權益 | 20.225 | 21.285 | 17.914 | 25.886 | 33.615 |
已發行普通股總數 | 59.5822 | 59.426 | 59.426 | 59.3958 | 59.3885 |
Total Preferred Shares Outstanding | 1.26018 | 1.26018 | 1.26018 | 1.26018 | 1.30268 |
長期債務 | 49.941 | 39.828 | 29.734 | 29.504 | 29.275 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -38.776 | -30.527 | -23.465 | -13.294 | -13.9 |
經營活動産生的現金 | -31.056 | -24.308 | -20.601 | -10.848 | -10.179 |
經營活動産生的現金 | 0 | ||||
非現金物品 | 2.752 | 2.468 | 1.922 | 1.805 | 4.793 |
營運資金的變化 | 4.968 | 3.751 | 0.942 | 0.641 | -1.072 |
投資活動産生的現金 | 0 | 0 | 0 | ||
資本支出 | 0 | ||||
融資活動産生的現金 | 10 | 36.814 | 0.263 | 50.075 | 15.379 |
股票的發行(報廢),淨額 | 0 | 6.814 | 0.263 | 50.469 | 15.379 |
現金淨變化 | -21.056 | 12.506 | -20.338 | 39.227 | 5.2 |
Total Cash Dividends Paid | 0 | -0.394 | |||
其他投資現金流量項目,總計 | 0 | 0 | |||
債務的發行(退還),淨額 | 10 | 30 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -11.527 | -38.776 | -28.142 | -19.545 | -9.932 |
Cash From Operating Activities | -10.793 | -31.056 | -23.817 | -15.47 | -8.042 |
Non-Cash Items | 1.607 | 2.752 | 2.206 | 1.176 | 0.719 |
Changes in Working Capital | -0.873 | 4.968 | 2.119 | 2.899 | 1.171 |
Cash From Financing Activities | 10 | 10 | 0 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | -0.793 | -21.056 | -23.817 | -15.47 | -8.042 |
Issuance (Retirement) of Debt, Net | 10 | 10 | 0 | 0 | |
Cash From Investing Activities | 0 | ||||
Other Investing Cash Flow Items, Total | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
Suite 240
4960 Peachtree Industrial Boulevard
NORCROSS
GEORGIA 30071
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 555.000 多名交易者,選擇與 Capital.com 交易